Contrary to what is often seen in research, AHCC is just a brand name and does not stand for Active Hexose Correlated Compound, which is only one of its components.

In a study of 195 stage-four cancer patients, 60% saw a 50% or more tumor reduction in four weeks or less after taking 6 grams of AHCC daily.

For synergistic effects, AHCC can be stacked with Vitamin C, glutathione or NAC, and ETAs (an asparagus extract that boosts heat shock proteins).

In safety studies, researchers were unable to find a toxic dose of AHCC, even when giving rats the human equivalent of 600 grams.

Unlike supplements that just boost or suppress the immune system, AHCC is an immunomodulator that can do both simultaneously, making it potentially useful for both infections and autoimmune conditions.

A 2022 double-blind clinical trial showed that taking 3 grams of AHCC daily resulted in a 63.6% clearance rate for high-risk, persistent HPV in six months.

Every batch of AHCC produced worldwide originates from a single, patented master sample of hybridized mushroom mycelia created in a Japanese lab in 1986.

AHCC's unique culturing process creates small alpha-glucans (5,000 daltons) that are far more bioavailable than the large beta-glucans (200,000 daltons) in typical mushroom supplements.